ISX and hepatocellular carcinoma: In Tables 6, 7, 8, and 9, the clinical and pathological characteristics of 377 patients with HCC according to mRNA expression of ISX–BRD4, ISX–PCAF, PCAF–BRD4, and ISX–PCAF–BRD4 were, respectively, shown.